Identification of premature ovarian failure patients with underlying autoimmunity

Journal of Women's Health and Gender-Based Medicine

Volumn 9, Issue 3, 2000, Pages 275-287

  Yan, Gang ^a   Schoenfeld, David ^a   Penney, Cara ^a   Hurxthal, Kathy ^a   Taylor, Ann E ^a   Faustman, Denise ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Massachusetts General Hospital ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CD8 ANTIGEN; CELL SURFACE MARKER; HLA ANTIGEN CLASS 1; SMOOTH MUSCLE ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE;

ADOLESCENT; ADRENAL GLAND; ADULT; ANTIBODY DETECTION; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MACROPHAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTES; OVARIAN FAILURE, PREMATURE;

EID: 0034051847     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/152460900318461     Document Type: Article

References (29)

1. Powell CM, Taggart RT, Drumheller TC, et al. Molecular and cytogenetic studies of an X; autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet 1994;52:19.
2. Bondy CA, Nelson LM, Kalantaridou SN. The genetic origins of ovarian failure. J Women's Health 1998;7:1225.
3. Bannatyne P, Russell P, Shearman RP. Autoimmune oophoritis: A clinicopathologic assessment of 12 cases. Int J Gynecol Pathol 1990;9:191.
4. Grossman C. Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis. J Steroid Biochem 1989;34:241.
5. Sedmak DD, Hart WR, Tubb RR. Autoimmune oophoritis: A histopathologic study of involved ovaries with immunologic characterization of the mononuclear infiltrate. Int J Gynecol Pathol 1987;6:73.
6. Gloor E, Hurlimann J. Autoimmune oophoritis. Am J Clin Pathol 1984;81:105.
7. Wolfe CDA, Stirling RW. Cystic ovarian enlargement resulting from autoimmune oophoritis. Obstet Gynecol 1988;74:492.
8. de Moraes-Ruehsen M, Blizzard RM, Garcia-Bunuel R, Jones GS. Autoimmunity and ovarian failure. Obstet Gynecol 1972;112:693.
9. Biscotti CV, Hart WR, Lucas JG. Cystic ovarian enlargement resulting from autoimmune oophoritis. Obstet Gynecol 1989;74:492.
10. Sutton C. The limitations of laparoscopic ovarian biopsy. J Obstet Gynaecol Br Commonw 1974;81:317.
11. Walfish PG, Gottesman IS, Shewchuk AB, et al. Association of premature ovarian failure with HLA antigens. Tissue Antigens 1983;21:168.
12. Anasti JN, Adams S, Kimzey LM, et al. Karyotypically normal spontaneous premature ovarian failure: Evaluation of association with the class II major histocompatibility complex. J Clin Endocrinol Metab 1994; 78:722.
13. Taylor AE. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 1998;27:877.
14. Tung KSK, Smith S, Tuescher T, Cook C, Anderson RE. Murine autoimmune oophoritis, epididymoorchitis, and gastritis induced by day 3 thymectomy: Immunopathology. Am J Pathol 1987;126:293.
15. Tung KSK, Smith S, Matzner P, et al. Murine autoimmune oophoritis, epididymoorchitis, and gastritis induced by day 3 thymectomy: Autoantibodies. Am J Pathol 1987;126:293.
16. Check JH, Nowroozi K, Chase JS, et al. Ovulation induction and pregnancies in 100 consecutive women with hypergonadotropic amenorrhea. Fertil Steril 1990; 53:811.
17. Check JH, Chase JS. Ovulation induction in hypergonadotropic amenorrhea with estrogen and human menopausal gonadotropin therapy. Fertil Steril 1984; 42:919.
18. Corenblum B, Rowe T, Taylor PJ. High dose, shortterm glucocorticoids for the treatment of infertility resulting from premature ovarian failure. Fertil Steril 1993;59:988.
19. Nelson LM, Kimzey LM, White BJ, Merriam GH. Gonadotropin suppression for the treatment of karyotypically normal spontaneous premature ovarian failure: A controlled trial. Fertil Steril 1992;57:50.
20. Faustman D, Li X, Lin HY, et al. Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. Science 1991;254:1756.
21. Vidal-Puig A, Faustman DL. Tolerance to peripheral tissue is transient and maintained by tissue specific class I expression. Transplant Proc 1994;26:3314.
22. + lymphocyte subpopulation in prediabetic subjects. Diabetes 1991; 40:590.
23. Faustman DL. Occult CD45 T cell developmental defect in type I diabetes. Diabetes Metab 1993;19:446.
24. Fu Y, Nathan DM, Li F, Li X, Faustman DL. Defective major histocompatibility complex class I expression on lymphoid cells in autoimmunity. J Clin Invest 1993; 91:2301.
25. Fu Y, Yan G, Shi L, Faustman D. Antigen processing and autoimmunity. Evaluation of mRNA abundance and function of HLA-linked genes. Ann NY Acad Sci 1998;842:138.
26. Taylor AE, Adams JM, Mulder JE, et al. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea. J Clin Endocrinol Metab 1996;81:3615.
27. Pestano GA, Zhou Y, Trimble LA, et al. Inactivation of misselected CD8 T cells by CD8 gene methylation and cell death. Science 1999;284:1187.
28. Zelen M. The analysis of several $2/times $2 contingency tables. Biometrika 1971;58:129.
29. Li F, Hauser SL, Linan MJ, Stein MC, Faustman DL. Reduced expression of peptide-loaded HLA class I molecules on multiple sclerosis lymphocytes. Ann Neurol 1995;38:147.